ase fatality rate (follow-up 27 weeks); (d) ICU admission rate (follow-up 27 weeks).
• Comparison of hydroxychloroquine vs. placebo for the prevention of COVID-19 in healthcare workers at risk. Double-blind RCT (NCT04328467, not yet recruiting). Prim